CompletedNot Applicable

The Changes of Body Fat Distribution in Obese Patients With PCOS After LSG

China153 participantsStarted 2020-05-01

Plain-language summary

Polycystic ovary syndrome (PCOS) is a common endocrine disorder, with a prevalence of 5% to 15% in premenopausal women. Patients with PCOS presents as abnormal menstruation, ovulation disorders and/or hyperandrogenemia, and often accompanied by insulin resistance and other metabolic abnormalities. Abdominal fat accumulation, overweightness and obesity are frequently present in patients with PCOS . Visceral adipose tissue (VAT) plays an important role in the pathogenesis of PCOS.Therefore，this study aim to investigate the changes of body fat distribution in obese women with PCOS after laparoscopic sleeve gastrectomy (LSG), and to explore the factors that may predict the changes in body fat distribution in PCOS patients after LSG.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Fmale aged 18- 45;
✓. Meet Rotterdam criteria(2003);
✓. body mass index (BMI)≥30 kg/m2

Exclusion criteria

✕. Gender is male;
✕. Younger than 18 years old or older than 45 years old ;
✕. secondary obesity due to endocrine disorders;
✕. history of malignant tumors; 5）sever hepatic and renal disease;

What they're measuring

VAT mass

Timeframe: 12 months

Trial details

NCT IDNCT04690634

SponsorShanghai 10th People's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-05-01

View on ClinicalTrials.gov More Polycystic Ovary Syndrome trials